Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology | May 17, 2020
Most read this week
Graefe's Archive for Clinical and Experimental Ophthalmology | May 17, 2020